Approval · Notice of Compliance 1503 · 2000
ZOMIG: Notice of Compliance 1503
Issued January 28, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1503
- Date
- January 28, 2000
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Migraine therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOMIG | 02238660 | Marketed |
Medicinal ingredients
- ZOLMITRIPTAN 2.5 MG per TAB